Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mencevax ACWY New Process vs Current Process
NCT00227422Phase 4Completed
- Sponsor
- GSK
- Start
- Jun 2005
- Modality
- Antibody-Drug Conjugates (ADCs), Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of meningococcal ACYW135 vaccine in meningococcal infection, sponsored by GSK. Started Jun 2005; status: completed.
02
Drugs
meningococcal ACYW135 vaccine
03
Conditions
meningococcal infection
Beyond the preview
Go deeper on NCT00227422.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00227422.